By Natalie Rahhal U.S. Health Editor
Published: 23:08 BST, 3 May 2021 | Updated: 23:08 BST, 3 May 2021
U.S. regulators are expected green light Pfizer's Covid vaccine to be given to teenagers between ages 12 and 15 as early as the end of this week, officials told the New York Times.
The shot was authorized for people ages 16 and up in December, and Pfizer has been in trials for teens since October of last year.Insurance Loans Mortgage Attorney Credit Lawyer
Expanding the trial to younger teenagers will make about 13 million additional Americans eligible for vaccination, a step that some see as critical to reaching herd immunity and improving safety as children return to school.
Others, however, have questioned whether vaccinating children is worth the risk, considering that only 471 children under age 18 have died of COVID-19, accounting for 0.1